Bovine Lactoferrin

Clinical support for low-cost tablets to treat coronavirus

Clinical support for low-cost tablets to treat coronavirus

By Nicola Gordon-Seymour

Chewable tablets or capsules formulated with dextrose or sorbitol and added bovine lactoferrin (bFL) offer a low cost and easy to produce preventative or clinical treatment for coronavirus strains, including COVID-19, according to a new study.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers